Authored By: Sarah
11 Jul 2024

 Extracorporeal Membrane Oxygenation Machines Market to grow by USD 145.04 million between 2024-2028

According to a research report “ Extracorporeal Membrane Oxygenation Machines Market” by Modality (Veno-venous and arterio-venous, Veno-arterial) Product (ECMO machines, Softwares) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 145.04 million at a CAGR of  5.92% during the forecast period. In the global healthcare landscape, the escalating burden of chronic cardiovascular and respiratory diseases (CVDs and CRDs) is a significant concern, leading to an increasing number of fatalities. Extracorporeal Membrane Oxygenation (ECMO) machines serve as essential life-support systems for managing patients afflicted by these debilitating conditions. CRDs, such as COPD, ARDS, and pulmonary embolism, pose a threat to individuals across age groups. Key causative factors include respiratory infections, smoking, and air pollution. ECMO technology plays a pivotal role in mitigating the risks of respiratory or cardiac failure for these patients..

Browse market data tables, figures, and in-depth TOC on “Extracorporeal Membrane Oxygenation Machines Market” by Modality (Veno-venous and arterio-venous, Veno-arterial) Product (ECMO machines, Softwares) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By Modality, the Veno-venous and arterio-venous segment is projected to dominate the market size in 2024.

The Extracorporeal Membrane Oxygenation (ECMO) machines market is experiencing significant growth due to the increasing prevalence of respiratory and cardiac diseases, particularly those related to COVID-19. These advanced life support systems offer temporary organ assistance, enabling patient recovery. Technology advancements have resulted in more efficient and user-friendly ECMO machines, featuring enhanced oxygenation, reduced complications, and superior monitoring capabilities, making them indispensable tools for healthcare providers.

By Product, ECMO machines  segment is expected to hold the largest market size for the year 2024.

In the extracorporeal membrane oxygenation (ECMO) market, veno-venous (VV) machines hold a significant market share due to their primary function of supporting respiratory systems. These machines, designed for lung assistance, utilize one or two cannulas inserted in large veins, typically in the leg or neck area. VV ECMO machines facilitate the draining of blood from the vein, followed by the addition of oxygen after carbon dioxide removal. The blood is then warmed and returned to the right side of the heart, making these devices essential for managing various chronic respiratory diseases.

North America is forecasted to hold the largest market size by region in 2024.

The North American market dominates the global Extracorporeal Membrane Oxygenation (ECMO) machines market in 2023, driven by the region's high prevalence of cardiovascular and respiratory diseases, increasing number of transplant procedures, and rising adoption of advanced medical devices. Key factors fueling growth include healthcare professionals' heightened awareness of ECMO's benefits and escalating healthcare expenditures. COPD, a common chronic respiratory condition, significantly contributes to market expansion in this region. Vendor presence and technological innovations further bolster the market's growth trajectory.

The Extracorporeal Membrane Oxygenation Machines Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Braile Biomedica
  • Chalice Medical Ltd.
  • CytoSorbents Corp.
  • Edwards Lifesciences Corp.
  • Eurosets Srl
  • Fresenius SE and Co. KGaA
  • Gen World Medical Devices
  • Getinge AB
  • Johnson and Johnson Services Inc.
  • LivaNova PLC
  • MC3 Cardiopulmonary
  • Medtronic
  • MicroPort Scientific Corp.
  • Nipro Corp.
  • OriGen Biomedical Inc.
  • Sechrist Industries Inc.
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Spectrum Medical Ltd.
  • Terumo Corp.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Extracorporeal Membrane Oxygenation (ECMO) machines market encompasses innovative technologies and solutions for remote monitoring, surgical procedures, and critical care medicine. This market caters to healthcare providers and specialty clinics, focusing on supply chain management, quality control, and patient safety. Medical device regulations play a crucial role in ensuring the biocompatibility and safety of these devices. Key market trends include technological advances in centrifugal pumps, enhanced oxygenators, and portable ECMO devices. The global market for ECMO machines is driven by major trends such as hospital acquisitions, clinical trials, and global market trends in chronic respiratory and cardiovascular conditions. Major players in this market include Braile Biomedica and CytoSorbents Corporation. The market is segmented geographically, with significant growth in the veno-venous segment due to its application in respiratory failures. The market also witnesses ongoing innovations in ECMO technology, such as specialized ECMO for neonatal and pediatric patients, and artificial intelligence integration for improved cardiopulmonary support. Advertisements and promotional activities provide company product insights, highlighting major trends and parent market analysis. Overall, the ECMO machines market continues to evolve, driven by advancements in technology and the growing demand for effective solutions in critical care medicine.

Market Research Overview

In the healthcare industry, the Extracorporeal Membrane Oxygenation (ECMO) Machines Market has witnessed significant growth due to the increasing prevalence of cardio-pulmonary disorders such as strokes, coronary heart diseases, and respiratory failure. These machines play a crucial role in providing oxygen-filled blood to the body while removing carbon dioxide, acting as an alternative to the heart and lungs during major surgeries or medical emergencies. Companies like Braile Biomedica and Medtronic have been at the forefront of innovation in this field, developing advanced algorithms to optimize the ECMO experience for patients. The market is driven by regulatory policies that encourage the use of such life-saving technologies and the ongoing technological advancements in the cardiopulmonary domain. Major trends in the ECMO Machines Market include the integration of heart-lung machines and the Liby System, which enhances the efficiency and effectiveness of the treatment. Parent market analysis reveals a growing demand for devices that cater to the needs of patients with cardio-pulmonary disorders, making the ECMO Machines Market a promising investment opportunity.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document